Novo gets US backing for Victoza cardiovascular data
admin 21st June 2017 Uncategorised 0US regulatory advisors are backing the claim that Novo Nordisk’s Victoza reduces cardiovascular risk in patients with diabetes.
More: Novo gets US backing for Victoza cardiovascular data
Source: News